Akili reduces workforce by 40% as it looks to move to non-prescription model - podcast episode cover

Akili reduces workforce by 40% as it looks to move to non-prescription model

Sep 14, 202310 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, September 14, 2023. Check out the show notes for links to the stories we discuss today at MassDevice.com/podcast. Aurora Spine this week launched its SiLO TFX MIS sacroiliac joint fixation system. Fast Five hosts Sean Whooley and Danielle Kirsh explain the system's design and when ti received regulatory nods. Wearables are in the news today. Awak raised $20 million in a Series B funding round for its wearable dialysis device. Hear how the wearable technology works and what the company plans to use proceeds for. Vaxess also raised money this week for a shelf-stable vaccine patch. Whooley explains the design of the patch and some of the well-known pharmaceutical companies that have shown interest in using the patch. Samsung's spinoff Wellysis won an FDA nod for its wearable ECG this week. Find out what the company envisions using the device for, what some of its features are and where it is already in the market.  Akili announced a second round of headcount reductions as it looks to change its business model to non-prescription treatment of ADHD. Whooley discusses which departments are being let go and the reason behind the business model switch.
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast
Akili reduces workforce by 40% as it looks to move to non-prescription model | Fast Five Medtech News Podcast - Listen or read transcript on Metacast